The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Spine Biologics Market Research Report:
The latest report by IMARC, titled “ Spine Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2 028
” " the global spine biologics market reached a value of US$ 2.0 Billion in 2022.
Spine biologics include varioustools that are generally used for performing spine fusion surgery. They are commonly utilized to treat deformities that occur due to spine trauma, degenerative disorders, and tumors. These tools are usually manufactured using biomaterials, including ceramics, polymers and glasses, that are safe in nature.
They aid in promoting bone growth and the healing process while minimizing the disruption of soft tissues. Additionally, spine biologics is considered to be a preferred alternative to spinal orthoses since itreduces the requirement of additional surgical procedures.
Request Free Sample Report: https://www.imarcgroup.com/spine-biologics-market/requestsample
The global market is primarily driven by significant growth in the healthcare sector. Moreover, a considerable increase in investments from private and public agencies across numerous countries to upgrade the existing healthcare infrastructure is creating a positive outlook for the market. Along with this, the rising prevalence of chronic and acute spinal disorders among the masses is providing a boost to the market growth across the globe. In line with this, the increasing geriatric population, which is more susceptible to musculoskeletal ailments, is also propelling the market growth.
Furthermore, continual technological advancements and the integration of third-dimensional (3D) imaging, robotics, and artificial intelligence (AI) technologies with spine biologics devices to assist healthcare professionals in performing complex spine surgeries are also positively influencing the market growth. Some of the other factors contributing to the market growth include increasing healthcare expenditure and extensive research and development (R&D) in medical science. On account of the aforementioned factors, the market is anticipated to grow at a CAGR of 4.15% during the forecast period (2023-2028).
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
Market Summary:
Breakup by Product:
• Spinal Allografts
• Machined Bones Allograft
• Demineralized Bone Matrix
• Bone Graft Substitutes
• Bone Morphogenetic Proteins
• Synthetic Bone Grafts
• Cell Based Matrix
Breakup by Surgery Type:
• Open Spine Surgery
• Minimally Invasive Spine Surgery
Breakup by End User:
• Hospitals
• Ambulatory Care Centers
• Spinal Surgery Centers
• Orthopedic Clinics
• Others
Breakup by Region:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
Competitive Landscape with Key Players:
• Arthrex Inc
• Alphatec Holdings Inc.
• Exactech Inc
• Johnson & Johnson
• Medtronic plc
• NuVasive Inc
• Orthofix Medical Inc.
• Stryker Corporation
• Wright Medical Group N.V.
• Zimmer Biomet View
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
